GL1X · GenesisL1 explorer

MolNFT v1 · #24573 · protein

Crystallographic and solution studies of N-lithocholyl insulin: a new generation of prolonged-acting insulins.

1UZ9: “Crystallographic and solution studies of N-lithocholyl insulin: a new generation of prolonged-acting insulins.”. X-ray diffraction, 4 ligands (CRS, UZ9, ZN). MolNFT v1 #24573 on GenesisL1: 3D structure, binding sites and pockets in…

PDB
1UZ9
Type
protein
Length
49 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Insulin
UniProt
P01308
Ligands
CRS, UZ9, ZN, CL

Structure

x-ray diffraction · 2 distinct chains · 67% helix, 4% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AInsulinprotein2157% helix, 5% strandP01308
BInsulinprotein2875% helix, 4% strandP01308

Ligands and binding sites

  • CRS · M-cresol · ligand · chains A, B
  • UZ9 · (2S)-2-amino-6-({(4R)-4-[(10R,13S)-10,13-dimethyl-3-oxohexadecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl}amino)hexanoic acid · ligand · chains A, B
  • ZN · Zinc ion · metal · chains B
  • CL · Chloride ion · ion · chains B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Interfaces

1 interface between chains.

  • A–B · 595 Ų buried · 6 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 3 disulfide, 1 covalent (disulfide, covalent ligand).

Compared structures

  • 1UZ9 · Crystallographic and solution studies of N-lithocholyl insulin: a new generation of… · the same entry in another collection · chain A against A, TM-score 1.00
  • P01308 · AlphaFold monomer V2.0 prediction for insulin (P01308) · a predicted model of the same protein · chain B against A, TM-score 0.50

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.